Tag Archives: BIOTECH

A Bright Future for Orphan Disease Indications

Chart

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation. Our research found that 2012 saw the greatest number of approvals of therapies for orphan indications going back all the way to 2000 (This count includes previously approved drugs with new, orphan indication approvals).   Overall, 24 therapies were approved in orphan indications last year, including drugs for Anthrax, Gaucher’s Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Ring

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, like any relationship, these tie-ups take work and both parties run the risk of ending up in tears. At BIO’s recent CEO & Investor Conference, a panel of industry veterans gathered to discuss best practices in drug development partnering. Moderated by Jeff Stewart, Senior Engagement Manager with Campbell Alliance, the panel “Putting a Ring on it: When Drug Development Partnerships Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Thoughts on the President’s State of the Union

Jim Greenwood

I had several thoughts watching President Obama’s State of the Union Address tonight. First, we at BIO remain concerned about the possible impact that sequestration may have – specifically the potential impact it may have on human health. There are millions of patients – all hopeful that new treatments will become available soon. Our fear is that sequestration may impact the ability of those patients to access new treatments in a timely manner. That fear Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Governor Quinn Invites Biotech Professionals to Chicago

Gov Quinn

Governor Pat Quinn has long been a champion of the bioscience industry – both for its promise to help solve the world’s most pressing problems and as a means of elevating the economic development prospects for his state. The Governor has consistently championed educational reform, entrepreneurship, intellectual property protection, and industry regulation based on rigorous science. That is why he was named BIO’s Governor of the Year in 2011. We are furthermore honored that he Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Anti-Biotech Activist Changes Sides: “I discovered science”

Mark Lynas

If you missed last week’s report from the Oxford Farming Conference, Mark Lynas, the British writer and environmentalist who once helped drive Europe’s movement against biotech crops, apologized for those actions and embraced the technology as a vital tool for ending hunger and conserving the environment. The change of heart was widely reported in many mainstream outlets such as The New York Times, Los Angeles Times, Forbes, Discover magazine, Slate magazine and Science 2.0, among others. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,